Lovastatin

This classification denotes a naphthalene compound and hmg-coa reductase inhibitor, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9LHU78OQFD. European Medicines Agency schedules Lovastatin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08604MIG. Lovastatin generally arises in the molecular formula C24H36O5. The term LOVASTATIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 1, no. 4, 1987, list 27.) LOVASTATIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. As of Q4 2014, LOVASTATIN remains the US FDA Preferred Term for this commodity. Lovastatin bears US NLM identifiers UMLS ID C0024027 and NCI Concept Code C620. SMILES: O(C1C2C(C(C=CC2=CC(C1)C)C)CCC1OC(=O)CC(O)C1)C(=O)C(CC)C.